Publikationen von Suchorska, Bogdana

Vettermann, Franziska J., Diekmann, Caroline, Weidner, Lorraine, Unterrainer, Marcus, Suchorska, Bogdana, Ruf, Viktoria, Dorostkar, Mario, Wenter, Vera, Herms, Jochen, Tonn, Jörg-Christian, Bartenstein, Peter, Riemenschneider, Markus J. und Albert, Nathalie L. (2021) L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas. EJNMMI Research 11 (1).

Kaiser, Lena , Holzgreve, Adrien, Quach, Stefanie, Ingrisch, Michael, Unterrainer, Marcus, Dekorsy, Franziska J., Lindner, Simon, Ruf, Viktoria, Brosch-Lenz, Julia, Delker, Astrid, Böning, Guido, Suchorska, Bogdana, Niyazi, Maximilian, Wetzel, Christian H. , Riemenschneider, Markus J., Stöcklein, Sophia, Brendel, Matthias, Rupprecht, Rainer, Thon, Niklas, von Baumgarten, Louisa, Tonn, Jörg-Christian, Bartenstein, Peter, Ziegler, Sibylle und Albert, Nathalie L. (2021) Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas. Cancers 14 (1), S. 53. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian , Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. und Wirsching, Hans-Georg (2016) Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial. Neuro-Oncology 18 (4), S. 549-556. Volltext nicht vorhanden.